92783 ⎘
Carboxylic acid amides having carbon atoms of carboxamide groups bound to carbon atoms of rings other than six-membered aromatic rings having the nitrogen atoms of the carboxamide groups bound to hydrogen atoms or to carbon atoms of unsubstituted hydrocarbon radicals
NOVEL MONOMER AND CHEMICALLY RECYCLABLE POLYMER MATERIAL COMPRISING THE SAME
#2PROCESSES FOR THE PREPARATION OF N-(1-METHYLCYCLOPROPYL)-2-(3-PYRIDINYL)-2H-INDAZOLE-4-CARBOXAMIDE AND INTERMEDIATES THEREOF
#3COMPOUNDS FOR REDUCING NEUROINFLAMMATION
#4AMINE-BORANES AS BIFUNCTIONAL REAGENTS FOR DIRECT AMIDATION OF CARBOXYLIC ACIDS
#5N-SUBSTITUTED C6 CYCLYL CARBOXAMIDE COMPOUNDS AND USES THEREOF
#6NOVEL COMPOUND FOR CAPPING LAYER AND ORGANIC LIGHT EMITTING DEVICE INCLUDING SAME
#7NOVEL COMPOUND FOR LIGHT EMITTING DEVICE AND ORGANIC LIGHT EMITTING DEVICE INCLUDING SAME
#8COMPOUND FOR CAPPING LAYER AND ORGANIC LIGHT EMITTING DEVICE INCLUDING SAME
#9COMPOUNDS ADVANTAGEOUS IN THE TREATMENT OF CENTRAL NERVOUS SYSTEM DISEASES AND DISORDERS
#10COMPOUND FOR CAPPING LAYER AND ORGANIC LIGHT EMITTING DEVICE INCLUDING SAME
#11COMPOUND FOR CAPPING LAYER AND ORGANIC LIGHT EMITTING DEVICE INCLUDING SAME
#12COMPOSITIONS AND METHODS FOR TREATMENT OF PLATINUM-BASED CHEMOTHERAPEUTIC RESISTANT TUMORS
#13SULFUR AND AMIDE TROPOLONE INHIBITORS OF NUCLEOTIDYL TRANSFERASES AND USES THEREFOR
#14INDENYL COMPOUNDS, PHARMACEUTICAL COMPOSITIONS, AND MEDICAL USES THEREOF
#15Solid-state magnesium ion selective microelectrode and methods of production and use thereof
#16Amine-boranes as bifunctional reagents for direct amidation of carboxylic acids
#17Tricyclic amino containing compounds for treatment or prevention of symptoms associated with endocrine dysfunction
#18Tricyclic amino containing compounds for treatment or prevention of symptoms associated with endocrine dysfunction
#19Carbon-monoxide-releasing molecules and therapeutic applications thereof
#20Organic compounds having taste-modifying properties
#21NOVEL COMPOUNDS ADVANTAGEOUS IN THE TREATMENT OF CENTRAL NERVOUS SYSTEM DISEASES AND DISORDERS
#22Solvent composition for electronic device production
#23Process for the preparation of an amino-pyrimidine and intermediates thereof
#24Process for the preparation of enantiomerically and diastereomerically enriched cyclobutane amines and amides
#25LSD1 inhibitor and preparation method and application thereof
#26Method of treating or preventing Ras-mediated diseases
#27Indenyl compounds, pharmaceutical compositions, and medical uses thereof
#28Indenyl compounds, pharmaceutical compositions, and medical uses thereof
#29Indene derivatives and uses thereof
#30Indenyl compounds, pharmaceutical compositions, and medical uses thereof
#31Indenyl compounds, pharmaceutical compositions, and medical uses thereof
#32Methylmenthol derivative and cool-sensation imparter composition containing same
#33Heterocyclic inhibitors of the sodium channel
#34Tricyclic amino containing compounds for treatment or prevention of symptoms associated with endocrine dysfunction
#35Tricyclic amino containing compounds for treatment or prevention of symptoms associated with endocrine dysfunction
#36α- and γ-truxillic acid derivatives and pharmaceutical compositions thereof
#37Synthetic ligands that modulate the activity of the RhlR quorum sensing receptor
#38METHOD OF TREATING OR PREVENTING RAS-MEDIATED DISEASES
#39Substituted malonamides and their use as antibacterial drugs
#40PERFUME SYSTEMS
#41Processes for Preparing Quinoline Derivatives
#42Indenyl compounds, pharmaceutical compositions, and medical uses thereof
#43Physiological cooling compounds
#44Tricyclic Amino Containing Compounds for Treatment or Prevention of Symptoms Associated with Endocrine Dysfunction
#45Methyl menthol derivative and cooling agent composition containing same
#46Method of treating or preventing Ras-mediated diseases
#47Dental materials based on monofunctional vinylcyclopropane derivatives
#48Adamantane derivative compound
#49Compounds Which Have a Protective Activity with Respect to the Action of Toxins and of Viruses with an Intracellular Mode of Action
#50α- and γ-truxillic acid derivatives and pharmaceutical compositions thereof
#51Thickening stabilizer and thickening stabilization composition using same
#52HETEROCYCLIC INHIBITORS OF THE SODIUM CHANNEL
#53Tetracycline derivatives with reduced antibiotic activity and neuroprotective benefits
#54Physiological cooling compounds
#55Use of cyclohexanol derivatives as antimicrobial active compounds
#56Indenyl compounds, pharmaceutical compositions, and medical uses thereof
#57Compounds advantageous in the treatment of central nervous system diseases and disorders
#58Bicyclic compounds
#59Tetracycline derivatives with reduced antibiotic activity and neuroprotective benefits
#60Cosmetic compositions with tricyclodecane amides
#61COMPOSITIONS AND METHODS FOR THE TREATMENT OF DISEASE ASSOCIATED WITH TRP-P8 EXPRESSION
#62Alpha- and gamma-truxillic acid derivatives and pharmaceutical compositions thereof
#63Substituted cyclohexane compounds
#64Use of cyclohexanol derivatives as antimicrobial active compounds
#65Opsin-binding ligands, compositions and methods of use
#66Tricyclic amino containing compounds for treatment or prevention of symptoms associated with endocrine dysfunction
#671-AMINO-2-VINYLCYCLOPROPANE CARBOXYLIC ACID AMIDE AND SALT THEREOF, AND METHOD FOR PRODUCING SAME
#68Phenyl-substituted bicyclooctane-1,3-dione-derivatives
#69Tetracycline derivatives with reduced antibiotic activity and neuroprotective benefits
#70Inhibitors of the 11-beta-hydroxysteroid dehydrogenase type 1 enzyme
#71Novel compounds which have a protective activity with respect to the action of toxins and of viruses with an intracellular mode of action
#72INTERLEUKIN-1 AND TUMOR NECROSIS FACTOR-ALPHA MODULATORS; SYNTHESES OF SUCH MODULATORS AND METHODS OF USING SUCH MODULATORS
#73Compounds, pharmaceutical compositions and uses thereof
#74Processes for the preparation of optically active intermediates
#75PROCESS FOR MAKING NEO-ENRICHED p-MENTHANE COMPOUNDS
#76Bridged spiro [2.4] heptane derivatives as ALX receptor and/or FPRL2 agonists
#77Compositions and methods for the treatment of disease associated with TRP-P8 expression
#78Processes for preparing 1,2-substituted cyclopropyl derivatives
#79Methods and compositions for treatment of diabetes and dyslipidemia
#80TRP-P8 ACTIVE COMPOUNDS AND THERAPEUTIC TREATMENT METHODS
#81Derivatives of cycloalkyl- and cycloalkenyl-1,2-dicarboxylic acid compounds having formyl peptide receptor like-1 (FPRL-1) agonist or antagonist activity
#82Method for synthesis of (1S, 2R)-milnacipran
#831,1′-diadamantyl carboxylic acids, medicaments containing such compounds and their use
#84METHOD FOR PRODUCING OPTICALLY ACTIVE VINYLCYCLOPROPANECARBOXYLIC ACID DERIVATIVE AND OPTICALLY ACTIVE VINYLCYCLOPROPANEAMINO ACID DERIVATIVE
#85Inhibitors of the Shiga toxins trafficking through the retrograde pathway
#86Interleukin-1 and tumor necrosis factor-α modulators; syntheses of such modulators and methods of using such modulators
#87Chemical Process For Preparation Of Intermediates
#88Polymerizable higher diamondoid derivatives
#89New Terpenes And Macrocycles
#90Method for producing hydroxylated adaivjantane using cytochrome P450
#911-tert-Butylcyclohexanecarboxamide and uses thereof as cooling compounds
#92Compounds advantageous in the treatment of central nervous system diseases and disorders
#93Processes for the preparation of optically active intermediates
#94Process for the preparation of pharmaceutical intermediates
#95Substituted bicyclo [4.1.0] heptane-7-carboxylic acid amides and derivatives thereof as food flavor substances
#96Acylated indanyl amines and their use as pharmaceuticals
#97Alpha-halo- and alpha-alkyl-cyclopropylcarboxy compounds and uses thereof
#98Cobalt-catalyzed asymmetric cyclopropanation of alkenes with α-nitrodiazoacetates
#99ASYMMETRIC CYCLOPROPANATION OF ELECTRON-DEFICIENT OLEFINS WITH DIAZO REAGENTS
#100N-Substituted-P-Menthane-3-Carboxamide and Uses Thereof
#101Process for Preparing Amidrazones
#102Tetracycline derivatives with reduced antibiotic activity and neuroprotective benefits
#103Preparation for a cyclohexanecarboxylic acid derivative and intermediates
#104Process for cyclohexanecarboxylic acid derivatives
#105Process and intermediates for the preparation of (1,2,5)-6,6-dimethyl-3-azabicyclo[3,1,0]hexane-2-carboxylates or salts thereof
#106Cyclopropyl compounds and compositions for delivering active agents
#107Method and apparatus for the use of [C] carbon monoxide in labeling synthesis by photo-initiated carbonylation
#108Inhibitors of the 11-beta-hydroxysteroid dehydrogenase type 1 enzyme
#109PROCESS FOR PREPARING MENTHYLAMIDES
#110Cobalt-catalyzed asymmetric cyclopropanation of electron-deficient olefins
#11111-Beta-Hydroxysteroid Dehydrogenase Inhibitors
#112Substituted cyclopropanecarboxylic acid (3-methyl-cyclohexyl)amide as flavoring substance
#113Novel Interleukin-1 and Tumor Necrosis Factor-Alpha Modulators, Syntheses of Said Modulators and Their Enantiomers and Methods of Using Said Modulators
#114New Process 298
#115Chemical process for preparation of intermediates
#116Human G protein-coupled receptor and modulators thereof for the treatment of cell death-related disorders
#117Process and intermediates for the preparation of (1R,2S,5S)-6,6-dimethyl-3-azabicyclo[3,1,0]hexane-2-carboxylates for salts thereof
#118Novel Interleukin-1 and Tumor Necrosis Factor-Alpha Modulators, Syntheses of Said Modulators and Their Enantiomers and Methods of Using Said Modulators
#119Adamantyl acetamides as 11-β hydroxysteroid dehydrogenase inhibitors
#120Processes for the preparation of optically active intermediates
#121Interleukin-1 and tumor necrosis factor-αmodulators; syntheses of such modulators and methods of using such modulators
#122N,N′-substituted-1,3-diamino-2-hydroxypropane derivatives
#123Metal carboxylate salt nucleating or clarifying agent compounds and related polymer compositions and methods
#124Cannabinoid receptor modulators
#125Inhibitors of the 11-beta-hydroxysteroid dehydrogenase type 1 enzyme
#126Structural analogs of corosolic acid having anti-diabetic and anti-inflammatory properties
#127CYCLOALKYL INHIBITORS OF POTASSIUM CHANNEL FUNCTION
#128Acylated indanyl amines and their use as pharmaceuticals
#129Puleganic amides
#130Process
#131Method and apparatus for the use of [C] carbon monoxide in labeling synthesis by photo-initiated carbonylation
#132Interleukin-1 and tumor necrosis factor-α modulators, synthesis of said modulators and their enantiomers and methods of using said modulators
#133Process for preparing 3,3-disubstituted oxindoles and thio-oxindoles
#134Compounds as anti-inflammatory, immunomodulatory and anti-proliferatory agents
#135Inhibitors of the 11-beta-hydroxysteroid dehydrogenase type 1 enzyme
#136Adamantyl acetamides as 11-beta hydroxysteroid dehydrogenase inhibitors
#137Saturated and unsaturated N-alkamides exhibiting taste and flavor enhancement effect in flavor compositions
#138Coolant solutions and compositions comprising the same
#139Treatment of male sexual dysfunction
#140Analogs of isovaleramide, a pharmaceutical composition including the same, and a method of treating central nervous system conditions or diseases
#141Amido compounds and their use as pharmaceuticals
#142Cycloalkyl inhibitors of potassium channel function
#143Polymerizable higher diamondoid derivatives
#144Trp-p8 active compounds and therapeutic treatment methods
#145Cycloalkylamidoacid compounds, processes for making and uses thereof
#146Process and intermediates for the preparation of (1R,2S,5S)-6,6-dimethyl-3-azabicyclo[3,1,0]hexane-2-carboxylates or salts thereof
#147Compositions and methods for the treatment of disease associated with Trp-p8 expression
#148Tetraline derivatives as ghrelin receptor modulators